X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 10/Nov 22:10

Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +60.80% and +50.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates

zacks.com - 13/Nov 14:40

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +6.90% and +104.82%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates

zacks.com - 12/Nov 22:15

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +43.48% and -77.27%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates

zacks.com - 12/Nov 22:15

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +43.48% and -77.27%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Lags Revenue Estimates

zacks.com - 14/Nov 13:10

Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -4.86% and -18.85%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Lags Revenue Estimates

zacks.com - 14/Nov 13:10

Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -4.86% and -18.85%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates

zacks.com - 12/Nov 14:10

Astria Therapeutics (ATXS) delivered earnings and revenue surprises of -34.15% and -95.59%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates

zacks.com - 12/Nov 14:10

Astria Therapeutics (ATXS) delivered earnings and revenue surprises of -34.15% and -95.59%, respectively, for the quarter ended September 2025. Do the...

Sorry! Image not available at this time

Knightscope, Inc. (KSCP) Reports Q3 Loss, Beats Revenue Estimates

zacks.com - 12/Nov 23:50

Knightscope (KSCP) delivered earnings and revenue surprises of -36.11% and +14.69%, respectively, for the quarter ended September 2025. Do the numbers...

Sorry! Image not available at this time

Knightscope, Inc. (KSCP) Reports Q3 Loss, Beats Revenue Estimates

zacks.com - 12/Nov 23:50

Knightscope (KSCP) delivered earnings and revenue surprises of -36.11% and +14.69%, respectively, for the quarter ended September 2025. Do the numbers...

Sorry! Image not available at this time

Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates

zacks.com - 12/Nov 22:30

Pulmonx (LUNG) delivered earnings and revenue surprises of +15.00% and +4.10%, respectively, for the quarter ended September 2025. Do the numbers hold...

Les derniers communiqués